Mroske Cameron, Muci John, Wang Jicheng, Li Kai, Song Wenjia, Yan Jin, Feng Jinong, Liu Qiang, Sommer Steve S
Department of Molecular Genetics and Department of Molecular Diagnosis, City of Hope National Medical Center, Duarte, CA 91010, USA.
Anal Biochem. 2007 Sep 15;368(2):250-7. doi: 10.1016/j.ab.2007.05.024. Epub 2007 May 26.
Although DOVAM-S (detection of virtually all mutations-SSCP) in effect detects all mutations and is less costly than direct sequencing, the technique currently requires the use of radioactivity. F-DOVAM-S (fluorescent DOVAM-S) was developed to replace the isotopic label with fluorescence and to increase throughput via dye color multiplexing. As proof of principle, two multitemperature slab gel electrophoresis conditions were evaluated through the blinded analysis of mutations in the factor IX (FIX) genes of 88 hemophilia B (HB) patients and 7 wild-type controls. Using only two conditions, it was determined that F-DOVAM-S had a detection sensitivity of 97%. It is anticipated that when three or four optimized conditions are employed, F-DOVAM-S will detect all mutations. Three patient samples were multiplexed per well using three different fluorescent dyes (6FAM, VIC, and NED), demonstrating that it is possible to analyze up to 44 kb of diploid, color-coded amplification product per gel lane. This value corresponds to a throughput of approximately 4 Mb of DNA analyzed per 96-well gel, which is approximately triple that of conventional radiolabeled DOVAM-S. Throughput is further enhanced by the rapidity at which the fluorescent signal can be captured and the resultant multicolor chromatograms analyzed. Given these data, F-DOVAM-S has the potential to be a particularly powerful technology for clinical diagnosis because it allows the mutation analysis of multiple patients to be performed within 24h.
尽管DOVAM-S(几乎所有突变检测-单链构象多态性)实际上能检测所有突变,且成本低于直接测序,但该技术目前需要使用放射性物质。F-DOVAM-S(荧光DOVAM-S)的开发是为了用荧光取代同位素标记,并通过染料颜色多重化提高通量。作为原理验证,通过对88例B型血友病(HB)患者和7例野生型对照的因子IX(FIX)基因中的突变进行盲法分析,评估了两种多温度平板凝胶电泳条件。仅使用两种条件,就确定F-DOVAM-S的检测灵敏度为97%。预计当采用三或四种优化条件时,F-DOVAM-S将检测到所有突变。每个孔使用三种不同的荧光染料(6FAM、VIC和NED)对三个患者样本进行多重分析,表明每条凝胶泳道最多可分析44 kb的二倍体、颜色编码的扩增产物。该值对应于每96孔凝胶分析约4 Mb DNA的通量,约为传统放射性标记DOVAM-S的三倍。荧光信号捕获的速度以及由此产生的多色色谱图分析进一步提高了通量。基于这些数据,F-DOVAM-S有潜力成为一种特别强大的临床诊断技术,因为它能在24小时内对多个患者进行突变分析。